| 产品描述: | Nirmatrelvir (PF-07321332) 是一种有效的口服活性 SARS-CoV 3CLPRO 抑制剂。Nirmatrelvir (PF-07321332) 对 SARS-CoV-2 病毒有针对性,可用于 COVID-19 研究。 |
| 靶点: |
IC50: 3CLPRO |
| 体外研究: |
3CLPRO is responsible for cleaving polyproteins 1a and 1ab of SARS-CoV-2.1. Without the activity of the SARS-CoV-2 3CLPRO, nonstructural proteins (including proteases) cannot be released to perform their functions, inhibiting viral replication. |
| 参考文献: |
1. KoenVandyck, et al. Considerations for the Discovery and Development of 3-Chymotrypsin-Like Cysteine Protease Inhibitors Targeting SARS-CoV-2 Infection. Current Opinion in Virology Available online 27 April 2021 |
| 溶解性: |
DMSO : 100 mg/mL
Ethanol : 30 mg/mL |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.002 ml |
10.009 ml |
20.019 ml |
| 5 mM |
0.4 ml |
2.002 ml |
4.004 ml |
| 10 mM |
0.2 ml |
1.001 ml |
2.002 ml |
| 50 mM |
0.04 ml |
0.2 ml |
0.4 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |